{
    "nct_id": "NCT06816979",
    "official_title": "Assessing the CSF-ctDNA of Patients with Stage III and IV Non-Small Cell Lung Cancer: a Pilot Study",
    "inclusion_criteria": "* New histological diagnosis of stage III or IV NSCLC\n* For stage III/IV NSCLC patients without brain metastases, a documented mutation on lung cancer mutation panel (PULMOL) is required\n* Patient treated with radiation therapy and/or systemic therapy at Ohio State University\n* Estimated survival >= 1 year\n* No medical contraindication to lumbar puncture\nHealthy volunteers allowed",
    "exclusion_criteria": "* Patient has Alzheimer's, dementia, or mental disability\n* Patient is not able to receive MRI\n* Patient has allergy to xylocaine or any numbing medication for lumbar puncture\n* Previous cancer history prior to diagnosis of NSCLC\n* Pregnant or lactating women, or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception; this exclusion is necessary because the medication and radiation required for standard of care treatment has unknown effects on the unborn fetus",
    "miscellaneous_criteria": ""
}